Investigation of the virulence factors of multidrug-resistant Acinetobacter Baumannii isolates;Çok Ilaca Dirençli Acinetobacter baumannii Izolatlarinda Virülans Faktörlerinin Araştirilmasi

Mikrobiyoloji Bulteni

Volumn 48, Issue 1, 2014, Pages 70-81

  Eraç, Bayri ^a   Yilmaz, Fethiye Ferda ^a   Hoşgör Limoncu, Mine ^a   Öztürk, Ismail ^a   Aydemir, Şöhret ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Multidrug resistance; Virulence factors

Indexed keywords

VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BIOFILM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; MOVEMENT (PHYSIOLOGY); MULTIDRUG RESISTANCE; PATHOGENICITY; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BIOFILMS; BLOOD BACTERICIDAL ACTIVITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MOVEMENT; VIRULENCE; VIRULENCE FACTORS;

EID: 84897590207     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. McConnell MJ, Actis L, Pachon J. Acinetobacter baumannii: human infections, factors contributing to patho- genesis and animal models. FEMS Microbiol Rev 2013; 37(2): 130-55.
2. Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 2012; 3(3): 243-50.
3. Taşbakan MS, Pullukçu H, Korkmaz Ekren P, et al. Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii. Mlkrobiyol Bul 2009; 43(1): 61-70.
4. Karah N, Sundsfjord A, Towner K, Samuelsen Ø. Insights Into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 2012; 15(4): 237-47.
5. Cai X Chai D, Wang R, Liang B, Bai N. Colistin resistance of acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012; 67(7): 1607-15.
6. Kempf M, Rolain JM. Emergence of resistance to carbapenems in acinetobacter baumannii in Europe: clinical Impact and therapeutic options. Int J Antimicrob Agents 2012; 39 (2): 105-14.
7. Antunes LC, Imperi F, Carattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 2011; 6(8): e22674.
8. Aşik G. Current approaches to explain the virulence of Acinetobacter baumannii. Mlkrobiyol Bul 2011; 45(2): 371-80.
9. Luzzaro F, Mantengoli E, Perlil M, et al. Dynamics of a nosocomial outbreak of multldrug-reslstant Pseudo monas aeruginosa producing the PER-1 extended-spectrum ß-lactamase. J Clin Microbiol 2001; 39(5): 1865-70. (Pubitemid 32417035)
10. Soll DR. The Ins and outs of DNA fingerprinting the Infectious fungi. Clin Microbiol Rev 2000; 13(2): 332-70. (Pubitemid 30205430)
11. Tamura K, Dudley J, Nel M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24(8): 1596-9. (Pubitemid 47236692)
12. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation, j Microbiol Methods 2000; 40(2): 175-9.
13. Louden BC, Haarmann D, Lynne AM. Use of blue agar CAS assay for siderophore detection. J Microbiol Biol Educ 2011; 12(1): 51-3.
14. Benge GR. Bactericidal activity of human serum against strains of Klebsiella from different sources, J Med Microbiol 1988; 27(1): 11-5.
15. Eijkelkamp BA, Stroeher UH, Hassan KA, Papadimitrious MS, Paulsen IT, Brown MH. Adherence and motility characteristics of clinical Acinetobacter baumannii Isolates. FEMS Microbiol Lett 2011; 323(1): 44-51.
16. Yedekçi S, Eraç B, Hoşgör-Limoncu M. Detection of the efflux pump-mediated quinolone resistance in ESBL positive Escherichia coli and Klebsiella pneumoniae Isolates by phe-arg-ßeta-naphthylamide. Turk J Pharm Sci 2012; 9(1): 67-74.
17. Gur D, Korten V, Unal S, Deshpande LM, Castanhelra M. Increasing carbapenem resistance due to the clonal dissemination of oxadlllnase (OXA-23 and OXA-58)- producing Acinetobacter baumannii: report from the Turkish SENTRY program sites. J Med Microbiol 2008; 57(12): 1529-32.
18. Ergin A, Hascelik G, Eser OK. Molecular characterization of oxacillinases and genotyping of Invasive Acinetobacter baumannii Isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction In Ankara between 2004 and 2010. Scand J Infect Dis 2013; 45(1) : 26-31.
19. Gordon NC, Wareham DW. Multidrug-resistant acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010; 35(3): 219-26.
20. Lee HW, Koh YM, Kim J, et al. Capacity of multidrug-resistant clinical Isolates of Acinetobacter baumannii to form blofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008; 14(1): 49-54. (Pubitemid 350226570)
21. Cevahlr N, Demir M, Kaleli, Gürbüz M, Tikveşli S. Evaluation of biofilm production, gelatlnase activity and mannose-resistant hemagglutination In Acinetobacter baumannii strains, J Microbiol Immunol Infect 2008; 41(6):513-8.
22. Antunes LC, Imperi F, Towner KJ, Visca P. Genome-assisted identification of putative Iron-utilization genes In Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol 2011; 162(3): 279-84.
23. Cevahlr N, Kaleli, Demlr M, Yildirim U, Çevik E, Gürbüz M. Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains. Mlkrobiyol Bul 2006; 40(3): 251-5.
24. Doughari HJ, Ndakldemi PA, Human IS, Benade S. Virulence, resistance genes, and transformation amongst environmental Isolates of Escherichia coll and Acinetobacter spp. J Microbiol Biotechnol 2012; 22(1): 25-33.
25. Pannek S, Higgins PG, Steinke P, et al. Multidrug efflux inhibition in Adnetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother 2006; 57(5): 970-4.
26. Coban AY, Guney AK, Tanriverdi Cayci Y, Durupinar B. Effect of 1-(1-Naphtylmethyl)-piperazine, an efflux pump inhibitor, on antimicrobial drug susceptibilities of clinical Adnetobacter baumannii isolates. Curr Microbiol 2011; 62(2): 508-11.
27. Sun JR, Perng CL, Chan MC, et al. A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecydine resistance in Adnetobacter baumannii. PLoS One 2012; 7(11) : e49534.
28. Akin FE, Bayram A, Bald I. Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecydine in multi-resistant Adnetobacter baumannii isolates. Mikrobiyol Bul 2010; 44(2): 203-10.